Medical Research News
Focus on the latest clinical studies, reports, findings, programs and standards covering a wide spectrum of medical and health issues. This section highlights research into human populations and includes information about research facilities, funding, resources and public policy.
Biomed Industries, Inc. Comments on Roche’s Alzheimer’s Phase III Trial
In a news release dated November 14, 2022, Roche announced that their Alzheimer’s drug candidate, gantenerumab, did not perform meaningfully better than a placebo. About 25% of all patients who received gantenerumab were also associated with higher rates of an imaging abnormality that can... - November 19, 2022 - Biomed Industries Inc.
Pregmune Joins Digital Twin Consortium
Pregmune is thrilled to announce that has recently joined the Digital Twin Consortium (DTC), a global initiative created with the goal to be The Authority in Digital Twin(TM) as it relates to policy, security, interoperability, and overall development of digital twins. Founded in 2020 by Dr. - November 17, 2022 - Pregmune
DataJoint Launches New Cloud-Based System for Automating Neuroscience Experiments
DataJoint's New Cloud Solution Improves Lab Efficiency and Accuracy - November 11, 2022 - DataJoint
New Pivotal Data Demonstrates Clinical Feasibility of GeneFluidics’ Direct-from-Specimen AST in Clinical Settings
GeneFluidics, Inc. is pleased to announce a joint publication with the Medical College of Wisconsin (MCW) that introduces rapid antimicrobial susceptibility testing (AST), which would represent a paradigm shift in the clinical management of microbial infections. The data from the MCW study have... - November 04, 2022 - GeneFluidics Inc.
Long COVID Care Center Have Recently Published a Medical Report on the Symptoms of Long COVID Brain Fog
During rehabilitation after being infected with COVID-19, many patients said they experienced "brain fog." According to figures given in the study report, about 10% of patients infected with COVID-19 will experience long COVID. At present, it has become customary in the medical community to classify the symptoms of brain and nerve caused by COVID-19 infection as long-term COVID brain fog. - October 26, 2022 - Long COVID Care Center
Huntington Study Group Announces Results from the HD-Net Assessment on the State of Care for Huntington’s Disease in the United States
The Huntington Study Group (HSG), a world leader in clinical research for Huntington’s Disease (HD) for over 30 years, is pleased to announce the results from the novel HD-Net survey, which examined the United States Huntington’s disease (HD) care delivery in a variety of clinic settings by HD specialists and non-specialists. - October 25, 2022 - Huntington Study Group
Huntington Study Group Announces myHDstory™ Pilot Study: Making HD Voices Heard Has Reached Target Enrollment
The Huntington Study Group (HSG), a world leader in clinical research for Huntington’s Disease (HD) for over 30 years, is pleased to announce that the pilot study, Making HD Voices Heard, on the new online research platform, myHDstory™, has reached its enrollment target. “The HSG... - October 18, 2022 - Huntington Study Group
Kantify and Mcule Harness the Power of Data to Accelerate Drug Discovery
Kantify, using its AI technology for drug discovery and Mcule, with its compound sourcing platform, are collaborating to leverage data for better hit prediction. - October 17, 2022 - Mcule
Clubhouse International Awarded 2022 Honorary Pardes Humanitarian Prize in Mental Health
Clubhouse International is deeply honored to receive the Honorary 2022 Pardes Humanitarian Prize in Mental Health awarded by The Brain and Behavior Research Foundation. The Pardes Prize recognizes the Clubhouse Model of psychosocial rehabilitation as a rights-based approach to recovery that expands... - October 13, 2022 - Clubhouse International
Huntington Study Group Enrolls First Participant for Its Observational Study to Test the Reliability of the Virtual Use of the Unified Huntington’s Disease Rating Scale
The Huntington Study Group (HSG), a world leader in conducting clinical trials for Huntington’s Disease (HD) for over 30 years, together with its Clinical Research Organization (“CRO”), the HSG Clinical Research, Inc., today announces the enrollment of the first participant of its... - October 12, 2022 - Huntington Study Group
Mirror Biologics, Inc. Announces Additional $20 Million Investment to Close Out $30 Million Series A Investment Round
Mirror Biologics, Inc., a clinical stage biopharmaceutical company today announced the completion of the final $20 million tranche of its $30 million Series A investment round with Bradbury Asset Management (Hong Kong), Limited. Bradbury provided an initial $10 million tranche for this round in... - October 11, 2022 - Mirror Biologics, Inc.
The IPA Confirms IPAC2022NV Medical Conference at Alexis Park Resort in Las Vegas, NV with CME on Cannabis, Psilocybin, Psychedelics, Mental Health & More
The Integrative Providers Association (IPA) is holding its next Annual Integrative Providers Association Conference 2022 at the Alexis Park Resort in Las Vegas, Nevada, from November 13-15, 2022. Included in the IPACs are a variety of Edutainment and Networking Events, Engaging Pre-Recorded Content on Psychedelics, Cannabis and More with 15 AMA PRA Category 1 Credit(s)TM Centered Around Providers “Transitioning to Individualized Wellness Management” - Plus a Bonus Day-3 Clinical Practicum. - October 06, 2022 - Integrative Providers Association
ALS Therapy Development Institute Announces Superior Rail & Iron Works, Inc. as First Title Sponsor of White Coat Affair Gala
Superior Rail & Iron Works, Inc. will be the first Title Sponsor of the White Coat Affair gala, being held on October 15, 2022, at the Boston Sheraton to raise funds for ALS research. - September 28, 2022 - ALS Therapy Development Institute
New Decentralized Clinical Trial (DCT) Patient Satisfaction and Participation Report
800 Current and Future Clinical Trial Participants Link Satisfaction and Willingness to Participate with Decentralized Strategies - September 21, 2022 - Life Science Strategy Group, LLC
Biomed Industries, Inc. to Acquire MedAware Systems, Inc. to Expand Its Artificial Intelligence Research for Drug Discovery in Alzheimer’s Disease
Biomed Industries, Inc. (“BIOMED” or the “Company”), has entered into a share exchange agreement to acquire all of the issued and outstanding shares of MedAware Systems, Inc. MedAware shares was valued at $1.50 per share and BIOMED’s share was valued at $8.00 per share. The transaction was valued at an aggregate of $18 million, to be paid in the form of 2,259,170 common shares of BIOMED. On the date of the Agreement, BIOMED has approximately 76,354,075 common shares. - September 21, 2022 - Biomed Industries, Inc.
Serpin Pharma Awarded Competitive NCI Grant for SP16
The National Cancer Institute awarded Serpin Pharma a $400,000 competitive R43 grant for the Pre-clinical validation of phase II peptide LRP-1 agonist to treat and prevent chemotherapy-induced peripheral neuropathy. The Principal Investigators are Serpin Pharma's CEO and Executive Chairperson, Dr. - September 20, 2022 - Serpin Pharma, LLC
Vesalio Announces FDA Approval of the NeVa VS™ to Treat Cerebral Vasospasm After Aneurysmal Rupture
NeVa VS is a patented retrievable nitinol stent specifically designed to treat cerebral vasospasm after aneurysmal rupture. Delayed cerebral vasospasm is the leading cause of death and disability in patients who suffer an aneurysm rupture. - September 15, 2022 - Vesalio
NatureKue Introduces LiverSupport - Natural Dietary Supplement Supports Healthy Liver Function as It Reduces Fatty Deposits
NatureKue introduces LiverSupport, an herbal dietary supplement for adults who seek everyday support to help detoxify their liver, reduce accumulated fatty deposits in the liver, and help maintain healthy cholesterol and triglyceride levels. - September 06, 2022 - NatureKue
The Medical Center of Aurora Receives Prestigious Three-Star Rating from The Society of Thoracic Surgeons
The Medical Center of Aurora has earned a distinguished three-star rating from The Society of Thoracic Surgeons (STS) for its patient care and lung cancer resection outcomes. The three-star rating, which denotes the highest category of quality, places The Medical Center of Aurora among the elite... - August 31, 2022 - The Medical Center of Aurora
CABRI Announces Call for Proposals on Specialized Pro-Resolving Mediator Analytical Methods
The Cayman Biomedical Research Institute (CABRI) is offering research grants in amounts up to $100,000 to support essential research on specialized pro-resolving mediator (SPM) analytical methods. - August 26, 2022 - Cayman Chemical Company
Deadline Extended: CABRI Announces Undergraduate Fellowships and Scholarship Program
The Cayman Biomedical Research Institute (CABRI) is accepting applications from undergraduate students who have been offered an unpaid laboratory research position under an accredited principal investigator. Applications will be accepted from August 22 until September 18, 2022. - August 26, 2022 - Cayman Chemical Company
The Brooklyn Cancer Center Opens in Downtown Brooklyn
The Brooklyn Cancer Center (TBCC), a partnership between New York Cancer & Blood Specialists (NYCBS), one of the leading oncology practices in the nation, and The Brooklyn Hospital Center (TBHC), an independent community hospital in Fort Greene/Downtown Brooklyn, marked a major milestone today... - August 25, 2022 - New York Cancer & Blood Specialists
NanoCellect Biomedical Awarded $1.8M Federal Grant to Advance Imaging Flow Cytometry with Artificial Intelligence Technologies
NanoCellect Biomedical Inc., a leader in the development and manufacture of microfluidic cell sorting solutions for cell-based assays, today announced it has received a $1.8 million Phase II Small Business Innovation Research (SBIR) grant through the National Institutes of Health’s National... - August 24, 2022 - NanoCellect Biomedical
ClinicalPURSUIT’s State-of-the-Art EDC System Enables Researchers to Set Up Multicenter Studies in Weeks
The Missouri-based technology provider is helping clinical research and trials specialists set up multicenter studies in weeks through their technology. - August 19, 2022 - ClinicalPURSUIT
ClinicalPURSUIT is Transforming Clinical Research by Offering Powerful Data Capture Tools That Streamline Operations
The leading EDC technology provider is helping those involved in clinical research with powerful data capture tools that promote productivity and efficiency. - August 14, 2022 - ClinicalPURSUIT
NY Health Welcomes Urologist Raymond Khargi, MD
New York Health (NYHealth), the premier practice of primary and specialty care, is proud to announce the addition of board-certified urologist Raymond Khargi, MD. - August 03, 2022 - New York Health
New California Health Interview Survey (CHIS) COVID-19 Estimates Show Unvaccinated Adults Least Likely to Wear a Mask, Engage in Risk Reduction Behaviors
The UCLA Center for Health Policy Research's California Health Interview Survey has released preliminary COVID-19 estimates from April 2022, including responses to questions on risk reduction behaviors, such as masking, following state guidelines, and gathering with people outside their households; experience with long COVID; reasons for not being vaccinated or getting the booster; personal and financial impacts, such as reduction in hours, job loss, trouble paying bills; and more. - August 03, 2022 - UCLA Center for Health Policy Research
Experienced Gynecologic Oncologist Albert J. Steren, MD, FACOG, Joins Maryland Oncology Hematology
An accomplished and respected Dr. Steren is a surgeon with over 30 years of experience in gynecology and gynecologic oncology, joins the Rockville division of Maryland Oncology Hematology. - August 01, 2022 - Maryland Oncology Hematology
IVI and AcademyHealth Launch Project to Improve Measurement of Patient Healthcare Costs
Ensuring meaningful change in value assessment means recognizing the full economic impacts of serious health conditions on patients and caregivers. - July 27, 2022 - Innovation and Value Initiative
NY Health Appoints Vice President of Primary Care
New York Health (NYHealth) appoints Regina Primm as its Vice President of Primary Care. Primm has proven to be a prominent leader with more than a decade of experience working in healthcare. https://nyhealth.com/admin/regina-primm/ “I am honored to be given the opportunity to lead NY... - July 22, 2022 - New York Cancer & Blood Specialists
Heartland Pharmacy Creates New Collaborative Care Program
Heartland Pharmacy is launching a new senior care program to promote collaborative care for advanced physical wellness. - July 21, 2022 - Heartland Pharmacy
Julia Harwood Promoted to Senior Vice President of Clinical Operations for New York Cancer & Blood Specialists
New York Cancer & Blood Specialists (NYCBS) announced today the appointment of Julia Harwood to Senior Vice President of Clinical Operations. https://nycancer.com/news/julia-harwood-promoted-to-senior-vice-president-of-clinical-operations-for-new-york-cancer-and-blood-specialists Harwood... - July 20, 2022 - New York Cancer & Blood Specialists
Nick Giampaolo Appointed Senior Vice President of Operations for New York Cancer & Blood Specialists
New York Cancer & Blood Specialists (NYCBS) announces the appointment of Nick Giampaolo to Senior Vice President of Operations. Giampaolo will oversee expansion efforts in collaboration with the Chief Executive Officer and Chief Operating... - July 20, 2022 - New York Cancer & Blood Specialists
PharmStars Announces Spring 2022 Accelerator Graduates: 11 Digital Health Startups Have Successfully Completed PharmStars’ Pharma-Focused Accelerator Program
PharmStars, the pharma-focused accelerator for digital health startups, announces the graduation of 11 startups from its Spring 2022 program. The graduates successfully completed the 10-week PharmaU program, which culminated with the Showcase Event held June 8-10 in Boston. The Showcase Event brought together the participating startups and PharmStars’ seven innovation-minded pharma members. - July 12, 2022 - PharmStars
Immundiagnostik and Preventis GmbH Go Beyond the Lab at the AACC’s Annual Scientific Meeting and Clinical Lab Expo
Immundiagnostik and Preventis GmbH will exhibit together at the upcoming AACC Clinical Lab Expo July 26-28 in Chicago, IL in support of improved patient care. - July 11, 2022 - Immundiagnostik, Inc.
Team Arnav Foundation to Hold 3rd Annual Event
Public announcement telling folks to participate in a local event whose proceeds help eradicate pediatric osteosarcoma. - July 09, 2022 - Team Arnav Foundation
George Sotos, MD Named Practice President of Maryland Oncology Hematology
Maryland Oncology Hematology (MOH), the largest independent oncology practice in Maryland and a member of The US Oncology Network, has elected George Sotos, MD as the new practice President. Dr. Sotos succeeds Dr. Joseph Haggerty as of June 1 and will serve a three-year term. Dr. Sotos practices... - July 06, 2022 - Maryland Oncology Hematology
Kalimullah Quadri, MD Joins New York Cancer & Blood Specialists
New York Cancer & Blood Specialists (NYCBS), one of the leading oncology practices in the Nation, is pleased to announce that Kalimullah Quadri, MD has joined the team of oncologists-hematologists. He will be practicing at 447 Atlantic Avenue, Brooklyn, NY 11217, and 121 Dekalb Avenue,... - July 06, 2022 - New York Cancer & Blood Specialists
Aleksander Vayntraub, MD Joins New York Cancer & Blood Specialists
New York Cancer & Blood Specialists (NYCBS), one of the leading oncology practices in the nation, is pleased to announce that board-certified radiation oncologist Aleksander Vayntraub, MD, has joined the team of radiation oncologists. He will be practicing at NYCBS sites in Setauket, Patchogue,... - July 06, 2022 - New York Cancer & Blood Specialists
TrialX Launches a DEI Toolkit Within iConnect Platform to Tackle Diversity Challenges in Clinical Trial Recruitment
To overcome barriers to participation of diverse populations in clinical trials, TrialX launches a toolkit for sponsors and sites to create an end to end multilingual experience for patients. - June 21, 2022 - TrialX
Lead Medical is Honored in 24th Annual Digital Health Awards® Spring 2022 Session
Lead Medical’s Cath Lab Reporting System was selected as a winner at the 24th annual Digital Health Awards® program which recognizes the world’s best digital health resources. Receiving a Merit Award for Connected Digital Health, Lead Medical became the only Chinese digital health company recognized in the list of winners for the Spring 2022 session. - June 18, 2022 - Lead Medical
PharmStars Announces “Innovations in Real-World Evidence” Theme for Fall 2022 Accelerator
PharmStars, the pharma-focused accelerator for digital health startups, announces it is now accepting applications for its Fall 2022 cohort with the theme, “Innovations in Real-World Evidence.” - June 15, 2022 - PharmStars
PharmStars Announces Showcase Pitch Event for Spring 2022 Cohort
PharmStars, the pharma-focused accelerator for digital health startups, announces the start of its Showcase Event on June 8, 2022. The digital health startups that participated in the 10-week accelerator program will make formal presentations to, and answer questions from, the pharma members of PharmStars. All of PharmStars’ seven members are participating in the Showcase Event. - June 08, 2022 - PharmStars
Isaac Health Launches Affordable, Convenient Specialist Memory Clinic Services at Home
Isaac Health is a national provider of dementia care via a virtual platform from the safety of your home. They diagnose, treat, manage, and coordinate care for you in collaboration with your physician, loved ones, and/or senior living community - June 04, 2022 - Isaac Health
Eledon Announces Phase 2a Trial Results of Tegoprubart (AT-1501) – a Drug Invented at ALS TDI
Eledon Pharmaceuticals announced topline results from their Phase 2 trial of tegoprubart (formerly AT1501), a drug invented and developed at the ALS Therapy Development Institute (ALS TDI). The Phase 2a trial in ALS was a 12-week, open label, dose escalating, safety, and biomarker study. The... - May 31, 2022 - ALS Therapy Development Institute
Paradigm Immunotherapeutics to Present at LABEST 2022 Incubator Showcase
Dr. Neil Bodie, CEO of Paradigm, will discuss Paradigm’s groundbreaking biological, virtual mask in his presentation, “A Breakthrough in SARS CoV-2/COVID Prophylactics.” Dr. Neil Bodie, CEO of Paradigm Immunotherapeutics (“Paradigm”), will present at the Los Angeles... - May 25, 2022 - Paradigm Immunotherapeutics
ALS Therapy Development Institute Scientists to Present Posters Sharing Research Advancements at the ALS Drug Development Summit
The ALS TDI scientists will be showcasing significant advancements in ALS research through multiple poster presentations. These posters will cover pre-clinical research exploring potential new therapeutic drug-like molecules and targets for ALS, as well as translational research analyzing patient data to identify new ALS biomarkers, drug targets, and patient populations. - May 25, 2022 - ALS Therapy Development Institute
ASAcampus Involved Once Again in an Experiment That Will Take Place on the International Space Station
The experiment, selected by the European Space Agency in the ESA-ILSRA2014 call and with the support of the Italian Space Agency (C-ASI N. 2018-14-U.0-Suture in Space), aims to study the process of surgical wound healing in space. - May 22, 2022 - ASA srl
LifeBiotic's Botanical Formula Shows Significant Destruction of Multiple GI Cancer Cells
In a new cell model study, the patented LCS101 formula eliminated up to 90% of cancer cells within 72 hours. - May 19, 2022 - Lifebiotic
Vesalio Announces the Completion of Enrollment in Its FDA IDE Clinical Study for Acute Ischemic Stroke
Vesalio announces the completion of enrollment in its FDA IDE clinical study for acute ischemic stroke. - May 11, 2022 - Vesalio